- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.01. | Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting | 153 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting.
Election... ► Artikel lesen | |
| 12.11.25 | Simris Group AB receives observation status | 129 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| 12.11.25 | Simris Group AB: Simris Group Interim Report January-september 2025 | 154 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11.25 | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 183 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11.25 | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 169 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 06.10.25 | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 221 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09.25 | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 863 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08.25 | Simris Group AB: Simris Group Interim Report January-june 2025 | 205 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| 14.07.25 | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 191 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen | |
| 28.05.25 | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 317 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting.
Income... ► Artikel lesen | |
| 14.05.25 | Simris Group AB: Simris Group Interim Report January-march 2025 | 389 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7... ► Artikel lesen | |
| 26.02.25 | Simris Group AB: Simris Group Year-end Report January-december 2024 | 243 | GlobeNewswire (Europe) | QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK... ► Artikel lesen | |
| 04.02.25 | The observation status for Simris Group AB is removed | 348 | GlobeNewswire | On October 24, 2024, the shares in Simris Group AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,700 | -1,41 % | Analysten schlagen Alarm: Analyst sieht bei dieser Food-Tech-Aktie jetzt rund 100% Kurspotenzial | ||
| OATLY GROUP | 9,520 | -2,06 % | Game Changer: Steht hier jetzt die strukturelle Neubewertung nach einem Strategiewechsel bevor? | ||
| CONAGRA BRANDS | 14,700 | -1,58 % | Dividendenbekanntmachungen (27.01.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) CARPENTER TECHNOLOGY CORPORATION US1442851036 0,2 USD 0,1683 EUR CONAGRA BRANDS INC US2058871029 0,35 USD 0,2946 EUR TAYLOR MARITIME... ► Artikel lesen | |
| AGRARIUS | - | - | Agrarius AG: "Konzernjahresfehlbetrag sinkt von 2,37 auf 1,98 Mio. Euro - 221 Hektar Ackerland im Eigentum" - HV-Bericht von GSC-Research | - im Anhang finden Sie den HV-Bericht von GSC-Research.Anhang: HVAGRARIUS2025.pdfDen vollständigen Artikel lesen ... ► Artikel lesen | |
| WINGSTOP | 228,00 | -0,87 % | Jim Cramer Calls Wingstop (WING) "Too Tough a Call" | ||
| WH GROUP | 0,945 | +0,53 % | HSI Up 361 pts; HSTI Up 28 pts; CHINA LIFE Up over 5%; CHINA LIFE, AIA, HSBC HOLDINGS, CHINAHONGQIAO, WH GROUP Hit New Highs; Market Turnover Rises | ||
| MHP | 7,700 | +16,67 % | MHP becomes the First Ukrainian Agricultural Company to join the World Economic Forum as an Official Partner | KYIV, Ukraine, Jan. 28, 2026 /PRNewswire/ -- MHP has been granted Official Partner status by the World Economic Forum (WEF), becoming the first Ukrainian agricultural company to join this... ► Artikel lesen | |
| ELSE NUTRITION | 0,065 | 0,00 % | Else Nutrition Holdings Inc.: Else Nutrition Announces Results from Annual General Meeting of Shareholders | VANCOUVER, BC, Jan. 12, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that at its annual general... ► Artikel lesen | |
| JACK IN THE BOX | 18,300 | +0,55 % | Jack in the Box repays $105 million in debt | ||
| BIOGAIA | 10,510 | -1,41 % | BioGaia AB and University of Gothenburg discovered a new role for bacteria present in the gut: serotonin production | Often considered as our "second brain", the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous system)... ► Artikel lesen | |
| J&J SNACK FOODS | 77,00 | 0,00 % | Benchmark reiterates Buy rating on J&J Snack Foods stock with $130 target | ||
| PP LONDON SUMATRA INDONESIA | 0,048 | -6,80 % | XFRA NEW INSTRUMENTS AVAILABLE ON 08.12.2025 | The following instruments on XETRA do have their first trading 08.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 08.12.2025
Aktien
1 KYG4600C1107 Hope Life International... ► Artikel lesen | |
| CAVA GROUP | 62,72 | +0,58 % | Cava Athleisure in Talks to Raise US $ 3.81 million in funding | ||
| SUEDZUCKER | 9,925 | +3,82 % | BARCLAYS stuft Südzucker auf 'Underweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Südzucker von 10 auf 9 Euro gesenkt und die Einstufung auf "Underweight" belassen. Aufgrund der anhaltend schwachen... ► Artikel lesen | |
| NESTLE | 78,77 | -0,48 % | UBS stuft Nestle auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Nestle auf "Neutral" mit einem Kursziel von 78 Franken belassen. Sollte sich die Verunreinigung von Nestle-Milchpulver für... ► Artikel lesen |
Das Unternehmen SIMRIS GROUP AB kann der Branche Nahrungsmittel/Agrar zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,016 (+1.560 %) liegt der Kurs bei 0,017 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIMRIS GROUP AB finden Sie auf Wallstreet Online.